Javed Butler, MD, MPH, MBA - New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap Forward in Optimizing Patient Care?
PeerView Endocrinology & Diabetes CME/CNE/CPE Video Podcast06/10/19 • 31 min
Go online to PeerView.com/ZAZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in cardiovascular medicine explores the new frontiers in managing heart failure and the role of SGLT2 inhibitors in optimizing care for patients with or at risk of heart failure. Upon completion of this activity, participants should be better able to: Apply current recommendations designed to minimize the risks of hospitalizations and mortality in patients being treated for heart failure, Summarize current evidence regarding the potential therapeutic role, efficacy, and safety of SGLT2 inhibitors in the heart failure setting, Identify patients with or at risk of heart failure who could potentially derive benefit from therapy with SGLT2 inhibitors.
06/10/19 • 31 min
Generate a badge
Get a badge for your website that links back to this episode
Select type & size
<a href="https://goodpods.com/podcasts/peerview-endocrinology-and-diabetes-cmecnecpe-video-podcast-25449/javed-butler-md-mph-mba-new-frontiers-in-managing-heart-failure-are-sg-18306575"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to javed butler, md, mph, mba - new frontiers in managing heart failure: are sglt2 inhibitors the next leap forward in optimizing patient care? on goodpods" style="width: 225px" /> </a>
Copy